SXTP

60 Degrees Pharmaceuticals, Inc. SXTP

SXTP
60 Degrees Pharmaceuticals, Inc. CNSP
CNS Pharmaceuticals, Inc. CLDI
Calidi Biotherapeutics, Inc. SILO
Silo Pharma, Inc. CANF
Can-Fite BioPharma Ltd. CMND
Clearmind Medicine Inc. GRI
GRI Bio, Inc. KZIA
Kazia Therapeutics Limited JAGX
Jaguar Health, Inc. SNGX
Soligenix, Inc.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode SXTP CNSP CLDI SILO CANF CMND GRI KZIA JAGX SNGX
6M -65.07 % -29.75 % -61.11 % -34.62 % -77.15 % -93.05 % -73.13 % 32.20 % -58.52 % -20.30 %
YTD -88.53 % -90.88 % -90.61 % -58.47 % -86.60 % -95.73 % -97.56 % 2.29 % -95.89 % -55.27 %
1Y -87.05 % -90.21 % -92.14 % -55.34 % -83.57 % -94.93 % -97.25 % -39.73 % -95.41 % -53.70 %
3Y -99.73 % -99.99 % -99.89 % -86.85 % -96.25 % -99.95 % -100.00 % -67.10 % -99.97 % -99.15 %
5Y -99.73 % -100.00 % -99.89 % 12.71 % -98.70 % -99.97 % -100.00 % -98.06 % -100.00 % -99.59 %
10Y -99.73 % -100.00 % -99.89 % 12.71 % -99.95 % -99.97 % -100.00 % -98.01 % -100.00 % -99.95 %
Depuis le début -99.73 % -100.00 % -99.89 % 12.71 % -99.97 % -99.97 % -100.00 % -99.66 % -100.00 % -100.00 %

Dividende